Profusa, Inc.
For the period ended Dec 31, 2025. Filed Apr 15, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Apr 15, 2026
PFSA$0.55-0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Convertible Preferred Stock and Stockholders’ Deficit
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’
DEFICIT FOR THE YEARS ENDED DECEMBER 31, 2025 AND 2024
(IN THOUSANDS, EXCEPT SHARE AMOUNTS)
| Series A Convertible Preferred Stock · Series B Convertible Preferred Stock · Series C/C-1 Convertible Preferred Stock · Common Stock · Additional Paid-In · Accumulated · Total Stockholders’ | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Capital | Deficit | Deficit | |
| Balance at January 1, 2024 | 4,350,314 | $5,231 | 5,293,175 | $13,701 | 8,220,445 | $46,217 | 25,844 | $— | $5,732 | $(115,728) | $(109,996) |
| Stock-based compensation expense | — | — | — | — | — | — | — | — | 21 | — | 21 |
| Net loss | — | — | — | — | — | — | — | — | — | (9,230) | (9,230) |
| Balance at December 31, 2024 | 4,350,314 | 5,231 | 5,293,175 | 13,701 | 8,220,445 | 46,217 | 25,844 | — | 5,753 | (124,958) | (119,205) |
| Balance at January 1, 2025 | 4,350,314 | 5,231 | 5,293,175 | 13,701 | 8,220,445 | 46,217 | 25,844 | — | 5,753 | (124,958) | (119,205) |
| Conversion of preferred stock into common stock | (4,350,314) | (5,231) | (5,293,175) | (13,701) | (8,220,445) | (46,217) | 82,377 | — | 65,149 | — | 65,149 |
| Common stock issued to employees | — | — | — | — | — | — | 6,363 | — | 428 | — | 428 |
| Stock-based compensation expense | — | — | — | — | — | — | — | 463 | — | 463 | |
| Conversion of debt to common shares in connection with the merger | — | — | — | — | — | — | 197,098 | — | 46,891 | — | 46,891 |
| Issuance of common stock in connection with the merger and assumption of net liabilities of Northview | — | — | — | — | — | — | 86,432 | — | (8,400) | — | (8,400) |
| Issuance of inducement shares to related party in connection with the merger | — | — | — | — | — | — | 38,691 | — | 7,254 | — | 7,254 |
| Issuance in shares in connection with exercise of ELOC | — | — | — | — | — | — | 513,859 | — | 10,276 | — | 10,276 |
| Issuance of warrants in connection with exercise of ELOC Warrants | — | — | — | — | — | — | — | — | 982 | — | 982 |
| Issuance in shares in connection with exercise of ELOC Warrants | — | — | — | — | — | — | 12,000 | — | — | — | — |
| Issuance of warrants to financial advisor in connection with the merger | — | — | — | — | — | — | — | — | 330 | — | 330 |
| Issuance of shares in connection with the conversion of the PIPE note | — | — | — | — | — | — | 266,055 | — | 4,497 | — | 4,497 |
| Issuance of shares for settlement of merger transaction costs | — | — | — | — | — | — | 3,333 | — | 500 | — | 500 |
| Net loss | — | — | — | — | — | — | — | — | — | (35,823) | (35,823) |
| Balance at December 31, 2025 | — | $— | — | $— | — | $— | 1,232,052 | $— | $134,123 | $(160,781) | $(26,658) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.